The information contained in the Organizational Database (ODB) is provided for informational purposes only. There is no implied endorsement by NORD. NORD does not promote or endorse participation in any specific organization. The information is subject to change without notice. Every effort is made to ensure that the details for each entry are as current as possible.
Cat Eye Syndrome International
a/k/a: CESI onlus
via Casape 26
00156 Rome ITALY
+39- 6 -95 06 05 03
Cat Eye Syndrome International (CESI) is a non-profit organization that supports individuals and families affected by Cat Eye Syndrome (CES), also known as Schimd-Fraccaro Syndrome. The mission of CESI is to be a resource for the global CES community and to spread awareness about CES to the general public. In conjunction with medical and research professionals, CESI is compiling an international patient registry to catalogue various CES phenotypes. Currently CESI supports pre/post natal and newborn screening programs and the Adopt a Family Program, in which individuals can donate to support the financial needs of families coping with CES. Cat Eye Syndrome is a rare genetic disease caused by a partial trisomy or tetrasomy of part of chromosome 22. The name derives from the coloboma of the iris, which gives the eyes a cat-like appearance in about 50% of the patient population. Additional effects of the disease highly variable, but can include cause severe malformations of almost all organ systems. Some associated effects include misshapen ears with outgrowths of skin known as tags or pits, atresia of the anal canal, fistulas of the rectum to abnormal areas such as the bladder or vagina, and congenital heart, renal, and skeletal defects. Facebook Name: https://www.facebook.com/cateyessyndromeinternational; Twitter Handle: @CESIonlus - https://twitter.com/CESIonlus
The National Organization for Rare Disorders (NORD) web site, its databases, and the contents thereof are copyrighted by NORD. No part of the NORD web site, databases, or the contents may be copied in any way, including but not limited to the following: electronically downloading, storing in a retrieval system, or redistributing for any commercial purposes without the express written permission of NORD. Permission is hereby granted to print one hard copy of the information on an individual disease for your personal use, provided that such content is in no way modified, and that credit for the source (NORD) and NORD’s copyright notice are included on the printed copy. Any other electronic reproduction or other printed versions are strictly prohibited.
NORD's Rare Disease Information Database is copyrighted and may not be published without the written consent of NORD.